Development of adjuvant monarthritis is critically dependent on the induction protocol: comment on the article by Busso et al.
Ferrell
William
W
Kelso
Elizabeth
E
Lockhart
John
J
Dunning
Lynette
L
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000009:adverse effects*; D000818:Animals; D001172:Arthritis, Rheumatoid / Q000139:chemically induced; D004195:Disease Models, Animal; D005620:Freund's Adjuvant / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007150:Immunohistochemistry; D044464:Receptor, PAR-2 / Q000378:metabolism
D000276:Adjuvants, Immunologic; D044464:Receptor, PAR-2; D005620:Freund's Adjuvant